| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 340.15B | 322.56B | 303.03B | 279.31B | 245.42B |
| Gross Profit | 110.75B | 109.83B | 101.82B | 90.10B | 83.87B |
| EBITDA | 43.21B | 43.29B | 39.83B | 34.15B | 36.05B |
| Net Income | 17.33B | 20.87B | 19.89B | 14.77B | 18.05B |
Balance Sheet | |||||
| Total Assets | 327.61B | 319.17B | 292.16B | 239.09B | 236.60B |
| Cash, Cash Equivalents and Short-Term Investments | 51.55B | 56.76B | 44.30B | 32.17B | 59.00B |
| Total Debt | 38.04B | 36.55B | 27.04B | 1.85B | 2.00B |
| Total Liabilities | 105.83B | 104.10B | 91.07B | 56.41B | 53.14B |
| Stockholders Equity | 210.60B | 205.18B | 191.75B | 174.11B | 175.38B |
Cash Flow | |||||
| Free Cash Flow | 12.20B | 10.99B | -6.24B | -6.44B | 9.84B |
| Operating Cash Flow | 35.60B | 39.10B | 24.35B | 19.31B | 22.33B |
| Investing Cash Flow | -26.21B | -28.32B | -35.03B | -19.88B | 4.10B |
| Financing Cash Flow | -17.00B | 2.25B | 16.57B | -20.45B | -25.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥640.16B | 14.65 | 9.18% | 1.13% | 5.55% | 17.29% | |
66 Neutral | ¥383.88B | 21.98 | 7.90% | 1.95% | 5.45% | -16.23% | |
65 Neutral | ¥353.42B | 26.05 | 1.86% | 1.64% | 12.09% | 13.34% | |
64 Neutral | ¥81.69B | -88.15 | ― | 1.47% | 33.69% | 355.00% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
59 Neutral | ¥1.02T | 29.82 | 5.97% | 2.96% | 1.70% | -30.43% | |
59 Neutral | ¥49.72B | 13.18 | ― | 1.19% | 2.99% | 0.15% |